Position
CITIGROUP INC in Collegium Pharmaceutical, Inc
Back to the book · All holders of COLL
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $267.7K$2.57 → $2.84
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 2.28M | $5.86M | — | — | — | 0.0% |
| Q1 2026 | 973.4K | $2.77M | $2.84 | $267.7K | −$3.35M | 0.0% |